Affiliation:
1. Department of Surgical Oncology
2. Department of Molecular and Cellular Oncology
3. The Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas
4. Department of Visceral and Transplantation Surgery, Inselspital, University of Bern, Bern, Switzerland
5. Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center
Abstract
ABSTRACT
Nuclear factor κB (NF-κB) and activator protein 1 (AP-1) transcription factors regulate many important biological and pathological processes. Activation of NF-κB is regulated by the inducible phosphorylation of NF-κB inhibitor IκB by IκB kinase. In contrast, Fos, a key component of AP-1, is primarily transcriptionally regulated by serum responsive factors (SRFs) and ternary complex factors (TCFs). Despite these different regulatory mechanisms, there is an intriguing possibility that NF-κB and AP-1 may modulate each other, thus expanding the scope of these two rapidly inducible transcription factors. To determine whether NF-κB activity is involved in the regulation of
fos
expression in response to various stimuli, we analyzed activity of AP-1 and expression of
fos
,
fosB
,
fra-1
,
fra-2
,
jun
,
junB
, and
junD
, as well as AP-1 downstream target gene
VEGF
, using MDAPanc-28 and MDAPanc-28/IκBαM pancreatic tumor cells and wild-type, IKK1
−/−
, and IKK2
−/−
murine embryonic fibroblast cells. Our results show that
elk-1
, a member of TCFs, is one of the NF-κB downstream target genes. Inhibition of NF-κB activity greatly decreased expression of
elk-1
. Consequently, the reduced level of activated Elk-1 protein by extracellular signal-regulated kinase impeded constitutive, serum-, and superoxide-inducible c-
fos
expression. Thus, our study revealed a distinct and essential role of NF-κB in participating in the regulation of
elk-1
, c
-fos
, and
VEGF
expression.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology